Trytosaveabit commented on a stock · Apr 26 07:38

Finally it posted

$Biodexa Pharmaceuticals(BDRX.US)$ Biodexa Enters Into Exclusive License To eRapa, A Phase 3 Ready Asset For The Treatment Of Familial Adenomatous Polyposis; Worldwide Rights Come With $17M In Non-Dilutive Grant Funding For Pivotal Phase 3 Trial In FAP

Benzinga04/26/2024 08:34Follow

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

4788 Views

Comment

Trytosaveabit

2062Followers

31Following

25KVisitors